Clinical Trial Update: Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing dolutegravir with lopinavir/ritonavir as second-line HIV treatment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dolutegravir (dolutegravir)
• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2019-07-12